Table 1 Patient characteristics (n=50)
Characteristics | % | n |
|---|---|---|
Age (years) | ||
Median | 64 | |
Range | 46–79 | |
Histological type | ||
Serous | 78 | 39 |
Endometrioid | 4 | 2 |
Others | 18 | 9 |
Histological grade | ||
1 | 16 | 8 |
2 | 28 | 14 |
3 | 26 | 13 |
Unknown | 30 | 15 |
Number of earlier chemotherapy regimens | ||
One | 84 | 42 |
Two | 16 | 8 |
Response to earlier platinum–taxane regimen | ||
Clinical complete | 42 | 21 |
Clinical partial | 26 | 13 |
Stabilisation | 16 | 8 |
Progression | 10 | 5 |
Unknown | 6 | 3 |
Performance status | ||
0 | 32 | 16 |
1 | 68 | 34 |
Ascites | 48 | 24 |
Measurable lesion | ||
<5 cm | 40 | 20 |
⩾5 cm | 10 | 5 |
No (CA 125 ⩾40 UI ml–1) | 46 | 23 |
Not evaluable | 4 | 2 |
Number of disease sites a | ||
1 | 55 | 27 |
>1 | 45 | 23 |
